Navigation Links
Karolinska Development AB Announces Publication of Year End Report for 2009
Date:3/15/2010

STOCKHOLM, March 15, 2010 /PRNewswire/ -- Karolinska Development AB announces publication of its Year End Report 2009 on the company's website.

    Key events during the year:

    Group

    October - December 2009

    - Revenue increased by 8.3 % to 6.9 (6.4) MSEK.
    - Operating income amounted to -22.1 (-249.0) MSEK.
    - Profit after tax amounted to -19.4 (-246.4) MSEK.
    - Income per share before dilution amounted to -0.71 (-10.15) SEK.
    - Investments in portfolio companies during the period amounted to 27.1
      (65.0) MSEK.
    - Cashflow during the period 322.3 (55.5) MSEK.
    - Value of the total portfolio according to the International Private
      Equity and Venture Capital Valuation Board (IPEV Valuation Board)
      guidelines has at the balance sheet date been estimated at 1,512.3 MSEK
      compared to 1,321.8 MSEK as of December 31, 2008.

    January - December 2009

    - Revenue increased by 30.5 % to 30.3 (23.2) MSEK.
    - Operating income amounted to -13.5 (-70.5) MSEK.
    - Profit after tax amounted to -2.6 (-57.7) MSEK.
    - Income per share before dilution amounted to -0.10 (-2.34) SEK.
    - Investments in portfolio companies during the period amounted to 172.4
      (148.6) MSEK.
    - Cash flow during the period amounted to 204.8 (180.3) MSEK.

    Parent company

    January - December 2009

    - Revenue increased by 116.1 % to 6.7 (3.1) MSEK.
    - Operating loss amounted to -101.1 (-61.5) MSEK.

The entire report is available on http://www.karolinskadevelopment.com under Investors> Reports.

About Karolinska Development

Karolinska Development manages one of the largest portfolios of life science companies in Europe.

Using a unique, highly cost efficient business model, the management team guides the commercialization of world class life science innovations, helping to shape the next generation pharma industry. Since 2003, Karolinska Development has built a portfolio of some 40 companies. The portfolio includes a total of 19 potential first in class products. http://www.karolinskadevelopment.com

    Conny Bogentoft
    CEO Karolinska Development
    Tel: +46(0)706-68-61-43,
    e-mail: conny.bogentoft@karolinskadevelopment.com
    Karolinska Development AB (publ)
    Org.nr 556707-5048


SOURCE Karolinska Development AB

Back to top
'/>"/>
SOURCE Karolinska Development AB
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
2. 3 new honorary doctors at Karolinska Institutet
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
5. Karolinska Development Invests in EvoStem Finland Oy
6. Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
7. Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing Portfolio
8. Michael J. Fox Receives Honorary Doctorate From Karolinska Institute
9. Michael J. Fox to be made honorary doctor at Karolinska Institutet
10. Isolation of a new gene family essential for early development
11. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: